Towards a multidisciplinary, patient-centred care pathway
In recent years, the management of genitourinary cancers—including prostate, kidney, bladder, and testicular neoplasms—has seen significant progress, both from a diagnostic and therapeutic perspective. The real challenge, however, remains ensuring patients receive homogeneous, timely, and integrated clinical pathways between referral hospitals and local healthcare services.
Recently, a framework agreement was signed between the Fondazione Policlinico Tor Vergata and the ASL of Frosinone to establish a shared and structured pathway for the management of urological oncology patients, with a strong focus on multidisciplinarity and continuity of care.
A healthcare model that places the patient at the centre
The aim of this clinical-care pathway is to ensure that every patient can access high-complexity diagnostic and therapeutic pathways within the province of Frosinone, without having to face unnecessary travel or delays in diagnosing and treating delicate conditions.
Within this model, the reference structure is the UOSD of Robotic and Minimally Invasive Urology at Policlinico Tor Vergata, directed by Prof. Pierluigi Bove. Here, thanks to state-of-the-art technologies and highly specialised expertise, surgical management is guaranteed for cases that require it.
The strength of multidisciplinarity and territorial integration
The shared pathway is based on a multidisciplinary clinical evaluation of oncological cases from the very initial phase, carried out at ASL Frosinone. Once the therapeutic strategy has been defined, the patient may undergo surgical treatment at Tor Vergata using advanced robot-assisted, laparoscopic, and minimally invasive techniques.
The true innovation, however, lies in continuity of care: after surgery or specialist treatments, the patient returns to ASL Frosinone for follow-up and monitoring. This model avoids fragmentation of the care pathway, reduces waiting times, and keeps the individual and their quality of life at the centre of the entire healthcare process.
Advanced technology serving patient care
Technology plays a fundamental role in this integrated model. The use of robot-assisted surgery platforms, next-generation laparoscopic systems, and intraoperative imaging tools such as 3D/4K endoscopic towers and fluorescence-guided surgery techniques allows the surgical team to operate with extremely high levels of precision and safety.
Thanks to these technologies, combined with advanced clinical expertise, modern urological surgery can address complex tumours with an increasingly personalised, less invasive approach aimed at reducing the impact on post-operative quality of life.
An agreement looking towards the future
Beyond its clinical dimension, this project represents an important step forward in the organisation of regional oncology networks, fostering integration between hub centres and local services. The agreement, valid for one year but renewable, is part of a broader strategy to develop specialist clinical networks, enhancing expertise, technology, and clinical training.
The initiative also includes educational collaborations, such as agreements for internships for medical residents in various clinical areas, thereby strengthening the exchange of experience and expertise between healthcare and academic institutions.
The patient always at the core
As Prof. Bove often emphasises, the goal of every care pathway must be the person. In urological oncology, this means ensuring timely diagnoses, effective treatments, and continuity in clinical management, without unnecessary overlaps, inconvenience, or additional costs for the patient and the Regional Health Service.
In a context where urological cancers account for a significant proportion of neoplasms diagnosed each year, an integrated, patient-centred healthcare model is not merely desirable: it is both an organisational and human necessity.
Links to sourcesi:
“Urological cancers: the new integrated pathway between Policlinico Tor Vergata and ASL Frosinone approved” – FrosinoneToday.it
“Urological cancers: Policlinico Tor Vergata and ASL Frosinone approve framework agreement” – QuotidianoSanita.it
References:
Urological cancers, integrated clinical pathway, Policlinico Tor Vergata, ASL Frosinone, robotic urological surgery, multidisciplinary patient management, continuity of care, urological oncology, regional healthcare network, urological PDTA, quality of life in oncology patients, urological cancer diagnosis, urological follow-up, integrated territorial approach, Prof. Pierluigi Bove, URMI Tor Vergata, Lazio oncology network, robotic urological technology, minimally invasive surgery, hospital–territory collaboration, management of prostate kidney bladder cancers, healthcare innovation Lazio
